Amedeo Smart

Free Medical Literature Service


 

Amedeo

Kidney Transplantation

  Free Subscription

Articles published in
Transpl Int
    January 2022
  1. ESKANDARY F, Bohmig GA
    ABO-Incompatibility: Time to Challenge the Paradigm of Equivalence in Live-Donor Kidney Transplantation?
    Transpl Int. 2022;36:10281.
    >> Share

  2. DE SANDES-FREITAS TV, Cristelli MP, Requiao-Moura LR, Modelli de Andrade LG, et al
    Temporal Reduction in COVID-19-Associated Fatality Among Kidney Transplant Recipients: The Brazilian COVID-19 Registry Cohort Study.
    Transpl Int. 2022;36:10205.
    >> Share

  3. LIM WH, Ooi E, Pilmore HL, Johnson DW, et al
    Interactions Between Donor Age and 12-Month Estimated Glomerular Filtration Rate on Allograft and Patient Outcomes After Kidney Transplantation.
    Transpl Int. 2022;36:10199.
    >> Share

  4. PRONK MC, Burnapp L, Reinders MEJ, Massey EK, et al
    Relinquishing Anonymity in Living Donor Kidney Transplantation: Lessons Learned From the UK Policy for Anonymous Donors.
    Transpl Int. 2022;36:10091.
    >> Share

  5. WANG Y, Veltkamp DMJ, van der Boog PJM, Hemmelder MH, et al
    Illness Perceptions and Medication Nonadherence to Immunosuppressants After Successful Kidney Transplantation: A Cross-Sectional Study.
    Transpl Int. 2022;36:10073.
    >> Share

  6. CHANG A, Schaubel DE, Chen M, Abt PL, et al
    Trends and Outcomes of Hypothermic Machine Perfusion Preservation of Kidney Allografts in Simultaneous Liver and Kidney Transplantation in the United States.
    Transpl Int. 2022;35:10345.
    >> Share

  7. SCHIMPF J, Davidovic T, Abbassi-Nik A, Sprenger-Mahr H, et al
    Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients.
    Transpl Int. 2022;36:10357.
    >> Share

  8. CHALKLIN CG, Koimtzis G, Khalid U, Carrington-Windo E, et al
    SARS-CoV-2 Infection Can Lead to an Increase in Tacrolimus Levels in Renal Transplant Patients: A Cohort Study.
    Transpl Int. 2022;35:10127.
    >> Share

  9. HOD T, Ben-David A, Olmer L, Scott N, et al
    BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients.
    Transpl Int. 2022;35:10239.
    >> Share

  10. KROGSTAD V, Elgstoen KBP, Johnsen LF, Hartmann A, et al
    High Plasma Oxalate Levels Early After Kidney Transplantation Are Associated With Impaired Long-Term Outcomes.
    Transpl Int. 2022;35:10240.
    >> Share

  11. SHARMA A, Jorgensen DR, Mehta RB, Sood P, et al
    The Clinical Impact of Anti-HLA Donor Specific Antibody Detection Through First Year Screening on Stable Kidney Transplant Recipients.
    Transpl Int. 2022;35:10094.
    >> Share

  12. RANA MAGAR R, Knight S, Stojanovic J, Marks SD, et al
    Is Preemptive Kidney Transplantation Associated With Improved Outcomes when Compared to Non-preemptive Kidney Transplantation in Children? A Systematic Review and Meta-Analysis.
    Transpl Int. 2022;35:10315.
    >> Share

  13. SINGER J, Aouad LJ, Wyburn K, Gracey DM, et al
    The Utility of Pre- and Post-Transplant Oral Glucose Tolerance Tests: Identifying Kidney Transplant Recipients With or at Risk of New Onset Diabetes After Transplant.
    Transpl Int. 2022;35:10078.
    >> Share

  14. HUEGLI S, Jaques DA, De Seigneux S, Haidar F, et al
    Anasarca, and Lymphadenopathy in a Kidney Transplant Patient: A Diagnostic and Therapeutic Challenge.
    Transpl Int. 2022;35:10148.
    >> Share

  15. PAPALOIS V, Kotton CN, Budde K, Torre-Cisneros J, et al
    Impact of COVID-19 on Global Kidney Transplantation Service Delivery: Interim Report.
    Transpl Int. 2022;35:10302.
    >> Share

  16. CASTRO FILHO JBS, Pompeo JC, Machado RB, Goncalves LFS, et al
    Delayed Graft Function Under the Microscope: Surveillance Biopsies in Kidney Transplantation.
    Transpl Int. 2022;35:10344.
    >> Share

  17. TASAKI M, Tateno H, Sato T, Tomioka A, et al
    A Novel Method of CD31-Combined ABO Carbohydrate Antigen Microarray Predicts Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.
    Transpl Int. 2022;35:10248.
    >> Share

  18. DOBRIJEVIC ELK, Au EHK, Rogers NM, Clayton PA, et al
    Association Between Side of Living Kidney Donation and Post-Transplant Outcomes.
    Transpl Int. 2022;35:10117.
    >> Share

  19. TABBARA MM, Guerra G, Riella J, Abreu P, et al
    Creating a Single Inflow Orifice From Living Donor Kidney Allografts With Multiple Renal Arteries.
    Transpl Int. 2022;35:10212.
    >> Share

  20. MOREL A, Hoisnard L, Dudreuilh C, Moktefi A, et al
    Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy.
    Transpl Int. 2022;35:10228.
    >> Share

  21. SIMSIR M, Yildiz MG, Karatas M, Dalgic A, et al
    Hearing Impairments as an Overlooked Condition in Kidney Transplant Recipients.
    Transpl Int. 2022;35:10198.
    >> Share

  22. VENTURA-AGUIAR P, Bayes-Genis B, Amor AJ, Cuatrecasas M, et al
    Patient Experience in Pancreas-Kidney Transplantation-A Methodological Approach Towards Innovation in an Established Program.
    Transpl Int. 2022;35:10223.
    >> Share

  23. YAHAV D, Rahamimov R, Mashraki T, Ben-Dor N, et al
    Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study.
    Transpl Int. 2022;35:10204.
    >> Share

  24. PHILLPOTT M, Daga S, Higgins R, Lowe D, et al
    Dynamic Behaviour of Donor Specific Antibodies in the Early Period Following HLA Incompatible Kidney Transplantation.
    Transpl Int. 2022;35:10128.
    >> Share

  25. KRISHNAN A, Wong G, Teixeira-Pinto A, Lim WH, et al
    Incidence and Outcomes of Early Cancers After Kidney Transplantation.
    Transpl Int. 2022;35:10024.
    >> Share

  26. DOHERTY DT, Athwal V, Moinuddin Z, Augustine T, et al
    Kidney Transplantation From Hepatitis-C Viraemic Donors:Considerations for Practice in the United Kingdom.
    Transpl Int. 2022;35:10277.
    >> Share

  27. HELANTERA I, Snyder J, Asberg A, Cruzado JM, et al
    Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World Evidence.
    Transpl Int. 2022;35:10329.
    >> Share

  28. TANDUKAR S, Wu C, Hariharan S, Puttarajappa C, et al
    Impact of Size Matching Based on Donor-Recipient Height on Kidney Transplant Outcomes.
    Transpl Int. 2022;35:10253.
    >> Share

  29. KLOMP SD, Meziyerh S, Vissers MFJM, Moes DJAR, et al
    Increased Tacrolimus Exposure in Kidney Transplant Recipients With COVID-19: Inflammation-Driven Downregulation of Metabolism as a Potential Mechanism.
    Transpl Int. 2022;35:10269.
    >> Share

  30. PARK S, Yang SH, Kim J, Cho S, et al
    Clinical Significances of Anti-Collagen Type I and Type III Antibodies in Antibody-Mediated Rejection.
    Transpl Int. 2022;35:10099.
    >> Share

  31. FARD A, Pearson R, Lathan R, Mark PB, et al
    Perfusate Composition and Duration of Ex-Vivo Normothermic Perfusion in Kidney Transplantation: A Systematic Review.
    Transpl Int. 2022;35:10236.
    >> Share

  32. BECKER JU, Seron D, Rabant M, Roufosse C, et al
    Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as an Endpoint in Clinical Trials.
    Transpl Int. 2022;35:10141.
    >> Share

  33. NAESENS M, Loupy A, Hilbrands L, Oberbauer R, et al
    Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation.
    Transpl Int. 2022;35:10137.
    >> Share

  34. HILBRANDS L, Budde K, Bellini MI, Diekmann F, et al
    Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation.
    Transpl Int. 2022;35:10139.
    >> Share

  35. SERON D, Rabant M, Becker JU, Roufosse C, et al
    Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation.
    Transpl Int. 2022;35:10135.
    >> Share

  36. NAESENS M, Budde K, Hilbrands L, Oberbauer R, et al
    Surrogate Endpoints for Late Kidney Transplantation Failure.
    Transpl Int. 2022;35:10136.
    >> Share

  37. ROUFOSSE C, Becker JU, Rabant M, Seron D, et al
    Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation.
    Transpl Int. 2022;35:10140.
    >> Share

  38. BESTARD O, Thaunat O, Bellini MI, Bohmig GA, et al
    Alloimmune Risk Stratification for Kidney Transplant Rejection.
    Transpl Int. 2022;35:10138.
    >> Share

  39. TONG A, Oberbauer R, Bellini MI, Budde K, et al
    Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions.
    Transpl Int. 2022;35:10134.
    >> Share

  40. COOPER M, Schnitzler M, Nilubol C, Wang W, et al
    Costs in the Year Following Deceased Donor Kidney Transplantation: Relationships With Renal Function and Graft Failure.
    Transpl Int. 2022;35:10422.
    >> Share

  41. VILLANEGO F, Vigara LA, Cazorla JM, Naranjo J, et al
    Evaluation of Expanded Criteria Donors Using the Kidney Donor Profile Index and the Preimplantation Renal Biopsy.
    Transpl Int. 2022;35:10056.
    >> Share

  42. KANT S, Brennan DC
    Donor Derived Cell Free DNA in Kidney Transplantation: The Circa 2020-2021 Update.
    Transpl Int. 2022;35:10448.
    >> Share

  43. JUNG HY, Jeon Y, Huh KH, Park JB, et al
    Pretransplant and Posttransplant Alcohol Consumption and Outcomes in Kidney Transplantation: A Prospective Multicenter Cohort Study.
    Transpl Int. 2022;35:10243.
    >> Share

  44. GOPAL JP, McLean A, Crane J, Herbert P, et al
    Pancreas Transplantation in Black, Asian and Minority Ethnic Patients-Single Centre Experience in the UK.
    Transpl Int. 2022;35:10490.
    >> Share

  45. MOEINDARBARI T, Feizi M
    Kidneys for Sale: Empirical Evidence From Iran.
    Transpl Int. 2022;35:10178.
    >> Share

  46. RILEY S, Zhang Q, Tse WY, Connor A, et al
    Using Information Available at the Time of Donor Offer to Predict Kidney Transplant Survival Outcomes: A Systematic Review of Prediction Models.
    Transpl Int. 2022;35:10397.
    >> Share

  47. KILLIAN JT JR, Houp JA, Burkholder GA, Roman Soto SA, et al
    COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19.
    Transpl Int. 2022;35:10626.
    >> Share

  48. RANGEL EB, de Lucena DD, Aguiar-Brito I, de Andrade LGM, et al
    COVID-19 in Kidney Transplant Recipients With Diabetes Mellitus: A Propensity Score Matching Analysis.
    Transpl Int. 2022;35:10375.
    >> Share

  49. LANG JJ, Lombardi CV, James IA, Da Rocha-Afodu DB, et al
    A Payer's Perspective: A Comparison and Simulation of the Costs of Hemodialysis Versus Living Donor Kidney Transplant for Patients With End-Stage Renal Disease in Nigeria.
    Transpl Int. 2022;35:10662.
    >> Share

  50. DELPIRE B, Van Loon E, Naesens M
    The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants.
    Transpl Int. 2022;35:10465.
    >> Share

  51. COZZI E, Alvarez M, Carmona M, Mahillo B, et al
    An Analysis by the European Committee on Organ Transplantation of the Council of Europe Outlining the International Landscape of Donors and Recipients Sex in Solid Organ Transplantation.
    Transpl Int. 2022;35:10322.
    >> Share

  52. BUDDE K, Rostaing L, Maggiore U, Piotti G, et al
    Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe.
    Transpl Int. 2022;35:10225.
    >> Share

  53. NAESENS M, Schneeberger S
    Redefining Risk Stratification and Endpoints for Clinical Trials in Kidney Transplantation: Rationale and Methodology of Proposals Submitted to the European Medicines Agency by the European Society for Organ Transplantation.
    Transpl Int. 2022;35:10142.
    >> Share

  54. SIGURJONSDOTTIR VK, Purington N, Chaudhuri A, Zhang BM, et al
    Complement-Binding Donor-Specific Anti-HLA Antibodies: Biomarker for Immunologic Risk Stratification in Pediatric Kidney Transplantation Recipients.
    Transpl Int. 2022;35:10158.
    >> Share

  55. SATTLER A, Thumfart J, Toth L, Schrezenmeier E, et al
    SARS-CoV2 mRNA Vaccine-Specific B-, T- and Humoral Responses in Adolescents After Kidney Transplantation.
    Transpl Int. 2022;35:10677.
    >> Share

  56. RAVAL AD, Ganz ML, Fraeman K, Lorden AL, et al
    Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study.
    Transpl Int. 2022;35:10528.
    >> Share

  57. MAMODE N, Bestard O, Claas F, Furian L, et al
    European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group.
    Transpl Int. 2022;35:10511.
    >> Share

  58. URO-COSTE C, Atenza A, Heng AE, Rouzaire PO, et al
    Abatacept Rescue Therapy in Kidney Transplant Recipients: A Case Series of Five Patients.
    Transpl Int. 2022;35:10681.
    >> Share

  59. HALFON M, Stavart L, Venetz JP, Manuel O, et al
    Kidney Transplantation in Patients With Active SARS-CoV-2 Replication: An Initial Case Series.
    Transpl Int. 2022;35:10716.
    >> Share

  60. SHARIF A
    Deceased Donor Characteristics and Kidney Transplant Outcomes.
    Transpl Int. 2022;35:10482.
    >> Share

  61. SHIMADA S, Shamaa T, Ivanics T, Kitajima T, et al
    Liver Transplant Recipient Characteristics Associated With Worse Post-Transplant Outcomes in Using Elderly Donors.
    Transpl Int. 2022;35:10489.
    >> Share

  62. JI M, Wang M, Hu W, Ibrahim M, et al
    Survival After Simultaneous Pancreas-Kidney Transplantation in Type 1 Diabetes: The Critical Role of Early Pancreas Allograft Function.
    Transpl Int. 2022;35:10618.
    >> Share

    December 2021
  63. CHANDRA A, Malhotra KP, Rao NS, Singh AK, et al
    Recurrent proteinuria with graft dysfunction: a diagnostic and clinical conundrum.
    Transpl Int. 2021;34:2895-2896.
    >> Share

  64. KOENJER LM, Meinderts JR, van der Heijden OWH, Lely T, et al
    Comparison of pregnancy outcomes in Dutch kidney recipients with and without calcineurin inhibitor exposure: a retrospective study.
    Transpl Int. 2021;34:2669-2679.
    >> Share

  65. DESHPANDE PP, Jariwala S, Martin L, Golestaneh L, et al
    Impact of technology-based interventions on linking potential kidney donors and transplant candidates: a scoping review.
    Transpl Int. 2021;34:2781-2793.
    >> Share

  66. THOMAS CP, Gupta S, Freese ME, Chouhan KK, et al
    Sequential genetic testing of living-related donors for inherited renal disease to promote informed choice and enhance safety of living donation.
    Transpl Int. 2021;34:2696-2705.
    >> Share

  67. ROGERS R, Bodziak K, Cheema F, Chobanian M, et al
    Implementing a regional standardized BK polyomavirus screening protocol across eleven transplant centres.
    Transpl Int. 2021;34:2680-2685.
    >> Share

  68. CETINER M, Paul A, Treckmann JW, Dittmann S, et al
    Small donors for small recipients - excellent growth and long-term function of single kidney grafts.
    Transpl Int. 2021;34:2735-2745.
    >> Share

  69. MONTERO N, Toapanta N, Pallares N, Crespo M, et al
    Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution.
    Transpl Int. 2021;34:2494-2506.
    >> Share

  70. CHANDRA A, Malhotra KP, Rao NS, Singh AK, et al
    Recurrent proteinuria with graft dysfunction: a diagnostic and clinical conundrum.
    Transpl Int. 2021;34:2910-2912.
    >> Share

  71. LIU JY, Zhang JM, Zhan HS, Sun LY, et al
    EBV-specific cytotoxic T lymphocytes for refractory EBV-associated post-transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review.
    Transpl Int. 2021;34:2483-2493.
    >> Share

    November 2021
  72. ASGARISABET P, Rajan SS, Lee M, Morgan RO, et al
    The Beneficial Effect of Providing Kidney Transplantation Information on Transplantation Status Differs Between For-profit and Non-profit Dialysis Centers.
    Transpl Int. 2021 Nov 2. doi: 10.1111/tri.14151.
    >> Share

  73. PEREZ-BLANCO A, Lopez-Fraga M, Forsythe J, Pires Silva AM, et al
    Access of non-residents to transplantation of deceased donor organs: practices and strategies in the European setting.
    Transpl Int. 2021;34:2112-2121.
    >> Share

  74. PATRAS M, Decullier E, Lebbe C, Delyon J, et al
    Outcome of pretransplant melanoma after solid organ transplantation: an observational study.
    Transpl Int. 2021;34:2154-2165.
    >> Share

  75. GANDHI NV, Murad DN, Nguyen DT, Graviss EA, et al
    Hypertension and renal outcomes in normotensive kidney donors with multiple renal arteries.
    Transpl Int. 2021;34:2382-2393.
    >> Share

  76. REDEKER S, Massey EK, Boonstra C, van Busschbach JJ, et al
    Implementation of the kidney team at home intervention: Evaluating generalizability, implementation process, and effects.
    Transpl Int. 2021;34:2317-2328.
    >> Share

  77. AUGUSTO JF, Gatault P, Sayegh J, Garnier AS, et al
    Successful treatment of acute kidney allograft rejection using extracorporeal photopheresis in the context of post-transplant lymphoproliferative diseases: three successive cases.
    Transpl Int. 2021;34:2415-2417.
    >> Share

  78. KOWALEWSKA J, El Moudden I, Perkowska-Ptasinska A, Kapp ME, et al
    Assessment of the Banff Working Group classification of definitive BK polyomavirus nephropathy.
    Transpl Int. 2021;34:2286-2296.
    >> Share

    October 2021
  79. DE WEERD AE, van den Brand JAJG, Bouwsma H, de Vries APJ, et al
    ABO-incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity-matched analysis.
    Transpl Int. 2021 Oct 22. doi: 10.1111/tri.14145.
    >> Share

  80. AVNI-NACHMAN S, Yahav D, Nesher E, Rozen-Zvi B, et al
    Short versus prolonged antibiotic treatment for complicated urinary tract infection after kidney transplantation.
    Transpl Int. 2021 Oct 20. doi: 10.1111/tri.14144.
    >> Share

  81. PEREZ-SAEZ MJ, Juega J, Zapatero A, Comas J, et al
    Kidney transplant outcomes in elderly recipients with controlled donation after circulatory death or donation after brain death donors: A registry cohort study.
    Transpl Int. 2021 Oct 19. doi: 10.1111/tri.14141.
    >> Share

  82. PARAJULI S, Kaufman DB, Djamali A, Welch BM, et al
    Association of Human Leukocyte Antigen Mismatches Between Donor-recipient And Donor-donor in Pancreas after Kidney Transplant Recipients.
    Transpl Int. 2021 Oct 13. doi: 10.1111/tri.14138.
    >> Share

  83. JUNG HY, Jeon Y, Huh KH, Park JB, et al
    The Impact of Recipient and Donor Smoking in Living-Donor Kidney Transplantation: A Prospective Multicenter Cohort Study.
    Transpl Int. 2021 Oct 12. doi: 10.1111/tri.14137.
    >> Share

  84. LIM JH, Jeon Y, Lee SH, Lee YH, et al
    Declining trend of preemptive kidney transplantation and impact of pretransplant dialysis: a Korean nationwide prospective cohort study.
    Transpl Int. 2021 Oct 11. doi: 10.1111/tri.14135.
    >> Share

  85. LAI C, Yee SY, Ying T, Chadban S, et al
    Biomarkers as diagnostic tests for delayed graft function in kidney transplantation.
    Transpl Int. 2021 Oct 9. doi: 10.1111/tri.14132.
    >> Share

  86. TEGZESS E, Gomes Neto AW, Pol RA, de Boer SE, et al
    Comparative survival of elderly renal transplant recipients with a living donor versus a deceased donor: A retrospective single center observational study.
    Transpl Int. 2021 Oct 9. doi: 10.1111/tri.14130.
    >> Share

  87. COEMANS M, Senev A, Van Loon E, Lerut E, et al
    The evolution of histological changes suggestive of antibody-mediated injury, in the presence and absence of donor-specific anti-HLA antibodies.
    Transpl Int. 2021;34:1824-1836.
    >> Share

  88. ANDRES AM, Talayero P, Alcolea Sanchez A, Sanchez Galan A, et al
    Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long-term benefits.
    Transpl Int. 2021;34:1895-1907.
    >> Share

    September 2021
  89. VILLENEUVE C, Rerolle JP, Couzi L, Westeel PF, et al
    Therapeutic education as a tool to improve patient-reported and clinical outcomes after renal transplantation: results of the EPHEGREN multicenter retrospective cohort study.
    Transpl Int. 2021 Sep 29. doi: 10.1111/tri.14127.
    >> Share

  90. RUENROENGBUN N, Numthavaja P, Sapankaew T, Chaiyakittisopon K, et al
    "Efficacy and safety of conventional antiviral agents in preventive strategies for cytomegalovirus infection after kidney transplantation: a systematic review and network meta-analysis".
    Transpl Int. 2021 Sep 27. doi: 10.1111/tri.14122.
    >> Share

  91. WEHMEIER C, Amico P, Sidler D, Wirthmuller U, et al
    Pre-transplant donor-specific HLA antibodies and risk for poor first year renal transplant outcomes - Results from the Swiss Transplant Cohort Study.
    Transpl Int. 2021 Sep 24. doi: 10.1111/tri.14119.
    >> Share

  92. SCHMIDT-LAUBER C, Spoden M, Huber TB, Gunster C, et al
    Increased Rejection rates in kidney transplantations during the COVID-19 Pandemic.
    Transpl Int. 2021 Sep 23. doi: 10.1111/tri.14114.
    >> Share

  93. DOUWES RM, Vinke JSJ, Gomes-Neto AW, Ayerdem G, et al
    Type of Proton-Pump Inhibitor and Risk of Iron Deficiency in Kidney Transplant Recipients - Results from the TransplantLines Biobank and Cohort Study.
    Transpl Int. 2021 Sep 14. doi: 10.1111/tri.14110.
    >> Share

  94. RUBIN RA, Mehta M, Rossi A, Joeslon D, et al
    Endoscopic Ultrasound Guided Portal-systemic Pressure Gradient Measurement to Determine Candidacy for Kidney Transplant Alone vs. Combined Liver Kidney Transplant in Patients with Advanced Fibrosis or Cirrhosis.
    Transpl Int. 2021 Sep 12. doi: 10.1111/tri.14105.
    >> Share

  95. VAN ZANTEN R, de Weerd A, Betjes M, Boer-Verschragen M, et al
    Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial.
    Transpl Int. 2021;34:1703-1711.
    >> Share

  96. BLAZQUEZ-NAVARRO A, Dang-Heine C, Wehler P, Roch T, et al
    Risk factors for Epstein-Barr virus reactivation after renal transplantation: Results of a large, multi-centre study.
    Transpl Int. 2021;34:1680-1688.
    >> Share

  97. MAYER KA, Doberer K, Tillgren A, Viard T, et al
    Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
    Transpl Int. 2021;34:1689-1702.
    >> Share

  98. VAN LEEUWEN LL, Spraakman NA, Brat A, Huang H, et al
    Proteomic analysis of machine perfusion solution from brain dead donor kidneys reveals that elevated complement, cytoskeleton and lipid metabolism proteins are associated with 1-year outcome.
    Transpl Int. 2021;34:1618-1629.
    >> Share

    August 2021
  99. SAMPAIO MS, Lawrence Lum E, Homkrailas P, Gritsch HA, et al
    Outcomes of Small Pediatric Donor Kidney Transplants According to Donor Weight.
    Transpl Int. 2021 Aug 24. doi: 10.1111/tri.14026.
    >> Share

  100. OUAHMI H, Moceri P, Zorzi K, Albano L, et al
    Outcomes of kidney transplantation in patients with prosthetic heart valves.
    Transpl Int. 2021 Aug 23. doi: 10.1111/tri.14008.
    >> Share

  101. RIJKSE E, Qi H, Babakry S, Bijdevaate DC, et al
    To screen or not to screen? The development of a prediction model for aorto-iliac stenosis in kidney transplant candidates.
    Transpl Int. 2021 Aug 20. doi: 10.1111/tri.14013.
    >> Share

  102. MEKRAKSAKIT P, Boonpheng B, Leelaviwat N, Duangkham S, et al
    Risk Factors and Outcomes of Post-Transplant Erythrocytosis among Adult Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.
    Transpl Int. 2021 Aug 19. doi: 10.1111/tri.14016.
    >> Share

  103. GHIDINI F, De Corti F, Fascetti Leon F, Vidal E, et al
    Extraperitoneal kidney transplantation: a comparison between children weighting 15 kg. experience of a single institution.
    Transpl Int. 2021 Aug 19. doi: 10.1111/tri.14015.
    >> Share

  104. ERLANDSSON H, Qureshi AR, Scholz T, Lundgren T, et al
    Observational study of risk factors associated with clinical outcome among elderly kidney transplant recipients in Sweden - a decade of follow-up.
    Transpl Int. 2021 Aug 4. doi: 10.1111/tri.14004.
    >> Share

  105. LOMBARDI Y, Hiesse C, Ridel C, Touzot M, et al
    From combined heart-kidney to kidney transplantation program: what nephrologists should know about dilated cardiomyopathy.
    Transpl Int. 2021;34:1573-1575.
    >> Share

  106. AL AMMARY F, Yu S, Muzaale AD, Segev DL, et al
    Long-term kidney function and survival in recipients of allografts from living kidney donors with hypertension: a national cohort study.
    Transpl Int. 2021;34:1530-1541.
    >> Share

  107. LUQUE Y, Jamme M, Aubert O, Roux A, et al
    A kidney discard decision strategy based on zero-time histology analysis could lead to an unjustified increase in the organ turndown rate among ECD.
    Transpl Int. 2021;34:1506-1516.
    >> Share

  108. KLAGER J, Eskandary F, Bohmig GA, Kozakowski N, et al
    Renal allograft DARCness in subclinical acute and chronic active ABMR.
    Transpl Int. 2021;34:1494-1505.
    >> Share

    July 2021
  109. MARTIN K, Cantwell L, Barraclough KA, Lian M, et al
    Prolonged immunosuppression does not improve risk of sensitisation or likelihood of re-transplantation after kidney transplant graft failure.
    Transpl Int. 2021 Jul 28. doi: 10.1111/tri.13998.
    >> Share

  110. GOKMEN R, Cronin A, Brown W, Cass S, et al
    Kidney transplantation and patients who decline SARS-CoV-2 vaccination: an ethical framework.
    Transpl Int. 2021 Jul 19. doi: 10.1111/tri.13979.
    >> Share

  111. INGOLD L, Halter J, Martinez M, Amico P, et al
    Short- and long-term impact of neutropenia within the first year after kidney transplantation.
    Transpl Int. 2021 Jul 17. doi: 10.1111/tri.13976.
    >> Share

  112. GROTTENTHALER JM, Fuger JK, Mahling M, Konigsrainer A, et al
    Dynamics of glucose metabolism after liver transplantation: Prediabetes as a window of opportunity for patient survival and long-term kidney function.
    Transpl Int. 2021 Jul 2. doi: 10.1111/tri.13967.
    >> Share

  113. THOMAS R, Consolo H, Oniscu GC
    Have we reached the limits in altruistic kidney donation?
    Transpl Int. 2021;34:1187-1197.
    >> Share

  114. HUSAIN SA, King KL, Coley S, Natarajan K, et al
    Association between procurement biopsy findings and deceased donor kidney outcomes: a paired kidney analysis.
    Transpl Int. 2021;34:1239-1250.
    >> Share

    June 2021
  115. HOMKRAILAS P, Bunnapradist S
    Association between ethnicity and kidney transplant waitlist outcomes beyond estimated post transplant survival score.
    Transpl Int. 2021 Jun 30. doi: 10.1111/tri.13965.
    >> Share

  116. THEODORAKOPOULOU MP, Boutou AK, Pella E, Alexandrou ME, et al
    Cardiorespiratory fitness in kidney transplant recipients compared to patients with kidney failure: a systematic review and meta-analysis.
    Transpl Int. 2021 Jun 25. doi: 10.1111/tri.13961.
    >> Share

  117. JOACHIM E, Jorgenson MR, Astor BC, Smith JA, et al
    Pre-transplant bariatric surgery is not associated with an increased risk of infection after kidney transplant.
    Transpl Int. 2021 Jun 24. doi: 10.1111/tri.13958.
    >> Share

  118. MUHLBACHER J, Schorgenhofer C, Doberer K, Durr M, et al
    Anti-interleukin-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism.
    Transpl Int. 2021 Jun 21. doi: 10.1111/tri.13954.
    >> Share

  119. HELLEMANS R, Pengel L, Choquet S, Maggiore U, et al
    Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer (excluding non-melanoma skin cancer): overview of the available evidence and guidance for shared decision making.
    Transpl Int. 2021 Jun 19. doi: 10.1111/tri.13952.
    >> Share

  120. HUUSKES BM, Scholes-Robertson N, Guha C, Baumgart A, et al
    Kidney transplant recipient perspectives on telehealth during the COVID-19 pandemic.
    Transpl Int. 2021 Jun 11. doi: 10.1111/tri.13934.
    >> Share

  121. PANTHOFER AM, Lyu B, Astor BC, Singh T, et al
    Post-Kidney Transplant Serum Magnesium Exhibits a U-Shaped Association with Subsequent Mortality: An Observational Cohort Study.
    Transpl Int. 2021 Jun 3. doi: 10.1111/tri.13932.
    >> Share

  122. GAVRIILIDIS P, O' Callaghan JM, Hunter J, Fernando T, et al
    Allograft Nephrectomy versus Non-Allograft Nephrectomy after Failed Renal Transplantation: A Systematic Review by Updated Meta-Analysis.
    Transpl Int. 2021 Jun 1. doi: 10.1111/tri.13901.
    >> Share

  123. BESTARD O, Couzi L, Crespo M, Kessaris N, et al
    Stratifying the humoral risk of candidates to a solid organ transplantation: a proposal of the ENGAGE working group.
    Transpl Int. 2021;34:1005-1018.
    >> Share

  124. GAILLARD F, Jacquemont L, Lazareth H, Albano L, et al
    Living kidney donor evaluation for all candidates with normal estimated GFR for age.
    Transpl Int. 2021;34:1123-1133.
    >> Share

    May 2021
  125. JIA H, Huang F, Zhang X, Cheng J, et al
    Early perioperative fluid overload is associated with adverse outcomes in deceased donor kidney transplantation.
    Transpl Int. 2021 May 30. doi: 10.1111/tri.13926.
    >> Share

  126. LOMBARDI Y, Hiesse C, Ridel C, Touzot M, et al
    From combined heart-kidney to kidney transplantation program: What nephrologists should know about dilated cardiomyopathy.
    Transpl Int. 2021 May 24. doi: 10.1111/tri.13922.
    >> Share

  127. ROBERTSEN I, Asberg A, Jenssen TG, Gence B, et al
    Increased systemic exposure of once daily tacrolimus in renal transplant recipients on marine omega-3 fatty acid supplementation.
    Transpl Int. 2021 May 15. doi: 10.1111/tri.13917.
    >> Share

  128. MAGGIORE U
    Incomplete Recovery from COVID-19 associated Acute Kidney Injury (AKI) in Kidney Transplant Recipients: Prior Graft Injury Matters The Most.
    Transpl Int. 2021 May 7. doi: 10.1111/tri.13896.
    >> Share

  129. NEYENS T
    Did an effect of kidney transplantation on COVID-19 mortality go unnoticed due to selection bias?
    Transpl Int. 2021;34:773-775.
    >> Share

  130. OSMANODJA B, Mayrdorfer M, Halleck F, Choi M, et al
    Undoubtedly, kidney transplant recipients have a higher mortality due to COVID-19 disease compared to the general population.
    Transpl Int. 2021;34:769-771.
    >> Share

  131. HUGO C, Vehreschild J, Stecher M
    Response to Invited Commentary "Undoubtedly, kidney transplant recipients have a higher mortality due to COVID-19 disease compared to the general population".
    Transpl Int. 2021;34:771-773.
    >> Share

  132. HRUBA P, Madill-Thomsen K, Mackova M, Maluskova J, et al
    Three-month course of intragraft transcriptional changes in kidney allografts with early histological minimal injury - a cohort study.
    Transpl Int. 2021;34:974-985.
    >> Share

    April 2021
  133. FERREIRA AC, Mendes M, Silva C, Cotovio P, et al
    Bone densitometry versus bone histomorphometry in renal transplanted patients: A cross-sectional study.
    Transpl Int. 2021 Apr 28. doi: 10.1111/tri.13888.
    >> Share

  134. BACH C, Knaup KX, Herrmann M, Krumbiegel M, et al
    A non-invasive diagnostic approach to retrospective donor HLA-typing in kidney transplant patients using urine.
    Transpl Int. 2021 Apr 27. doi: 10.1111/tri.13893.
    >> Share

  135. FU Y, Cao Y, Wang H, Zhao J, et al
    Metabolic Outcomes and Renal Function after Simultaneous Kidney/Pancreas Transplantation compared with Kidney Transplantation Alone for Type 2 Diabetes Mellitus patients.
    Transpl Int. 2021 Apr 25. doi: 10.1111/tri.13892.
    >> Share

  136. OBI Y, Ichimaru N, Sakaguchi Y, Iwadoh K, et al
    Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients (CANDLE-KIT): a Multicenter, 2x2 Factorial, Open-label, Randomized Clinical Trial.
    Transpl Int. 2021 Apr 22. doi: 10.1111/tri.13885.
    >> Share

  137. IRENE BELLINI M, D'Andrea V, Rubulotta F, Spennati V, et al
    Postoperative delirium in kidney transplant patients.
    Transpl Int. 2021 Apr 21. doi: 10.1111/tri.13890.
    >> Share

  138. BAJPAI D, Deb S, Bose S, Gandhi C, et al
    Recovery of kidney function after AKI due to COVID-19 in kidney transplant recipients.
    Transpl Int. 2021 Apr 21. doi: 10.1111/tri.13886.
    >> Share

  139. NAEF B, Nilsson J, Wuethrich RP, Mueller TF, et al
    Intravenous Immunoglobulins Do Not Prove Beneficial to Reduce Alloimmunity among Kidney Transplant Recipients with BKV-Associated Nephropathy.
    Transpl Int. 2021 Apr 19. doi: 10.1111/tri.13882.
    >> Share

  140. VAN DELDEN C
    Is transplantation per se a risk factor for worse outcome of SARS-CoV-2 infection in kidney transplant recipients?
    Transpl Int. 2021 Apr 16. doi: 10.1111/tri.13879.
    >> Share

  141. TSUJITA M, Azhar A, Joglekar K, Talwar M, et al
    The Incidence of Hepatitis B Coinfection after Deceased-Donor Kidney Transplantation from Hepatitis C Infected Donors to Hepatitis C Negative Recipients.
    Transpl Int. 2021 Apr 8. doi: 10.1111/tri.13877.
    >> Share

  142. MESSNER F, Leemkuil M, Yu Y, Massie AB, et al
    Recipient age and outcome after pancreas transplantation: a retrospective dual-center analysis.
    Transpl Int. 2021;34:657-668.
    >> Share

  143. SCHREZENMEIER E, Lehner LJ, Merkel M, Mayrdorfer M, et al
    What happens after graft loss? A large, long-term, single-center observation.
    Transpl Int. 2021;34:732-742.
    >> Share

  144. TIMOFEEVA OA, Choe J, Alsammak M, Yoon EJ, et al
    Guiding therapeutic plasma exchange for antibody-mediated rejection treatment in lung transplant recipients - a retrospective study.
    Transpl Int. 2021;34:700-708.
    >> Share

    March 2021
  145. DE SANDES-FREITAS TV, Mazzali M, Manfro RC, de Andrade LGM, et al
    Exploring the causes of the high incidence of delayed graft function after kidney transplantation in Brazil: A multicenter study.
    Transpl Int. 2021 Mar 19. doi: 10.1111/tri.13865.
    >> Share

  146. KASTELZ A, Fernhall B, Wang E, Tzvetanov I, et al
    Personalized physical rehabilitation program and employment in kidney transplant recipients: A randomized trial.
    Transpl Int. 2021 Mar 18. doi: 10.1111/tri.13868.
    >> Share

  147. EKWENNA O, Lang J, Thomas I
    APOL1 screening of potential living kidney donors in resource-limited countries: an initial experience in Antigua & Barbuda and Nigeria.
    Transpl Int. 2021;34:590-592.
    >> Share

  148. PUNJALA SR, Adamjee Q, Silas L, Gokmen R, et al
    Weight trends in living kidney donors suggest predonation counselling alone lacks a sustainable effect on weight loss: a single centre cohort study.
    Transpl Int. 2021;34:514-524.
    >> Share

  149. AKIN EB, Soykan Barlas I, Dayangac M
    Hand-assisted retroperitoneoscopic donor nephrectomy offers more liberal use of right kidneys: lessons learned from 565 cases - a retrospective single-center study.
    Transpl Int. 2021;34:445-454.
    >> Share

  150. PFREPPER C, Herber A, Weimann A, Siegemund R, et al
    Safety and efficacy of direct oral anticoagulants under long-term immunosuppressive therapy after liver, kidney and pancreas transplantation.
    Transpl Int. 2021;34:423-435.
    >> Share

    February 2021
  151. HAJJAR R, Lafrance JP, Tchervenkov J, Gingras S, et al
    Successful surgical weight loss with laparoscopic sleeve gastrectomy for morbid obesity prior to kidney transplantation.
    Transpl Int. 2021 Feb 25. doi: 10.1111/tri.13855.
    >> Share

  152. GUPTA V, Ekundayo O, Nemeth ZK, Yang Y, et al
    Association between serum osteoprotegerin level and mortality in kidney transplant recipients.
    Transpl Int. 2021 Feb 19. doi: 10.1111/tri.13847.
    >> Share

  153. KHAIRALLAH P, Aggarwal N, Awan AA, Vangala C, et al
    The Impact of COVID-19 on Kidney Transplantation and the Kidney Transplant Recipient - One Year into the Pandemic.
    Transpl Int. 2021 Feb 5. doi: 10.1111/tri.13840.
    >> Share

  154. KUHN C, Lang BM, Lorcher S, Karolin A, et al
    Outcome of Kidney Transplantation from Very Senior Donors in Switzerland.
    Transpl Int. 2021 Feb 2. doi: 10.1111/tri.13836.
    >> Share

  155. HOSGOOD SA, Hoff M, Nicholson ML
    Treatment of transplant kidneys during machine perfusion.
    Transpl Int. 2021;34:224-232.
    >> Share

    January 2021
  156. GANDOLFINI I, Zanelli P, Palmisano A, Salvetti D, et al
    Anti-HLA and anti-SARS-CoV2 Antibodies in Kidney Transplant Recipient with COVID-19.
    Transpl Int. 2021 Jan 22. doi: 10.1111/tri.13829.
    >> Share

  157. HOMKRAILAS P, Sampaio M, Datta N, Danovitch GM, et al
    Impact of donor obesity on allograft outcomes after kidney transplantation adjusted for kidney donor profile index.
    Transpl Int. 2021 Jan 21. doi: 10.1111/tri.13826.
    >> Share

  158. SCHINSTOCK CA, Askar M, Bagnasco SM, Batal I, et al
    A 2020 Banff Antibody Mediated Injury Working Group examination of international practices for diagnosing antibody mediated rejection in kidney transplantation.
    Transpl Int. 2021 Jan 10. doi: 10.1111/tri.13813.
    >> Share

  159. MANGALGI S, Madan K, Das CJ, Singh G, et al
    Pulmonary infections after renal transplantation: a prospective study from a tropical country.
    Transpl Int. 2021 Jan 10. doi: 10.1111/tri.13817.
    >> Share

  160. HECKING M, Sharif A, Eller K, Jenssen T, et al
    Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics.
    Transpl Int. 2021;34:27-48.
    >> Share

  161. RO H, Jeong JC, Kong JM, Min JW, et al
    The tacrolimus metabolism affect post-transplant outcome mediating acute rejection and delayed graft function: analysis from Korean Organ Transplantation Registry data.
    Transpl Int. 2021;34:163-174.
    >> Share

  162. GREGORINI M, Ticozzelli E, Abelli M, Grignano MA, et al
    Kidney Transplants From Donors on Extracorporeal Membrane Oxygenation Prior to Death Are Associated With Better Long-Term Renal Function Compared to Donors After Circulatory Death.
    Transpl Int. 2022;35:10179.
    >> Share

  163. RODRIGUEZ-GONCER I, Ruiz-Ruigomez M, Lopez-Medrano F, Trujillo H, et al
    Cytomegalovirus Exposure and the Risk of Overall Infection After Kidney Transplantation: A Cohort Study on the Indirect Effects Attributable to Viral Replication.
    Transpl Int. 2022;35:10273.
    >> Share

  164. NETO HM, Tedesco Silva Junior H, Pestana JM, Foresto RD, et al
    Urological Complications Associated With Pyeloureterostomy Without Ipsilateral Nephrectomy in Renal Transplant Recipients.
    Transpl Int. 2022;35:10213.
    >> Share

  165. BEERLI N, Denhaerynck K, Binet I, Dahdal S, et al
    Age at Time of Kidney Transplantation as a Predictor for Mortality, Graft Loss and Self-Rated Health Status: Results From the Swiss Transplant Cohort Study.
    Transpl Int. 2022;35:10076.
    >> Share

  166. MORATH C, Hayek SS, Dohler B, Nusshag C, et al
    Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients.
    Transpl Int. 2022;35:10071.
    >> Share

  167. PIRKLBAUER M, Berger M, Boban MD, Tiefenthaler M, et al
    The Tangential Extraperitoneal Retrorenal Approach in Kidney Transplant Biopsy: An Observational Study to Assess Complication and Adequacy Rates.
    Transpl Int. 2022;35:10068.
    >> Share

  168. SCHIMPF J, Sprenger-Mahr H, Davidovic T, Lhotta K, et al
    Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients.
    Transpl Int. 2022;35:10060.
    >> Share

  169. NIMMO A, Graham-Brown M, Griffin S, Sharif A, et al
    Pre-Kidney Transplant Screening for Coronary Artery Disease: Current Practice in the United Kingdom.
    Transpl Int. 2022;35:10039.
    >> Share

  170. HALLER MC, Kaiser RA, Langthaler S, Brandstetter C, et al
    Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
    Transpl Int. 2022;35:10026.
    >> Share

  171. MAASSEN H, Leuvenink HGD, van Goor H, Sanders JF, et al
    Prolonged Organ Extraction Time Negatively Impacts Kidney Transplantation Outcome.
    Transpl Int. 2022;35:10186.
    >> Share

    December 2020
  172. BLACK JT, Haroon U, Barnes SC, Mayaleh S, et al
    Seroprevalence of SARS-CoV-2 IgG antibodies in the current COVID-19 pandemic amongst co-workers at a UK renal transplant centre.
    Transpl Int. 2020 Dec 15. doi: 10.1111/tri.13791.
    >> Share

  173. DE PAULA MI, Bowring MG, Shaffer AA, Garonzik-Wang J, et al
    Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti-thymocyte globulin (rATG) without CMV prophylaxis.
    Transpl Int. 2020 Dec 12. doi: 10.1111/tri.13800.
    >> Share

  174. PIPELEERS L, Abramowicz D, Broeders N, Lemoine A, et al
    5-Year outcomes of the prospective and randomized cistcert study comparing steroid withdrawal to replacement of cyclosporine with everolimus in de novo kidney transplant patients.
    Transpl Int. 2020 Dec 5. doi: 10.1111/tri.13798.
    >> Share

  175. KIM DG, Lee J, Kim MS, Kwon OJ, et al
    Outcomes of ABO-incompatible kidney transplantation in older patients: a national cohort study.
    Transpl Int. 2020 Dec 1. doi: 10.1111/tri.13794.
    >> Share

    November 2020
  176. CHEN CC, Lin WC, Lee CY, Yang CY, et al
    Two-year protocol biopsy after kidney transplantation in clinically stable recipients.
    Transpl Int. 2020 Nov 5. doi: 10.1111/tri.13785.
    >> Share

  177. MONTAGUD-MARRAHI E, Molina-Andujar A, Rovira J, Revuelta I, et al
    The impact of functional delayed graft function in the modern era of kidney transplantation.
    Transpl Int. 2020 Nov 1. doi: 10.1111/tri.13781.
    >> Share

  178. LIM WH, Wong G
    Complex kidney donors: should we stretch our limits?
    Transpl Int. 2020;33:1390-1392.
    >> Share

  179. GRINYO JM
    Renal allograft performance in immigrant transplant recipients.
    Transpl Int. 2020;33:1387-1389.
    >> Share

    October 2020
  180. YAO J, Clayton PA, Wyburn K, Choksi H, et al
    Paediatric kidney transplants from donors aged 1 year and under: an analysis of The Australian and New Zealand Dialysis And Transplant Registry (ANZDATA) From 1963 To 2018.
    Transpl Int. 2020 Oct 17. doi: 10.1111/tri.13772.
    >> Share

  181. ABD ELHAFEEZ S, Noordzij M, Kramer A, Bell S, et al
    The association of living donor source with patient and graft survival among kidney transplant recipients in the ERA-EDTA Registry.
    Transpl Int. 2020 Oct 6. doi: 10.1111/tri.13759.
    >> Share

  182. KOVANDOVA B, Slavcev A, Honsova E, Erhartova D, et al
    De Novo HLA Class II Antibodies Are Associated with the Development of Chronic but not Acute Antibody-Mediated Rejection after Liver Transplantation.
    Transpl Int. 2020 Oct 5. doi: 10.1111/tri.13763.
    >> Share

  183. ZIMMERMAN A
    Expecting the unexpected: COVID-19 in Kidney Transplant Recipients within United Network for Organ Sharing Region 1.
    Transpl Int. 2020 Oct 1. doi: 10.1111/tri.13757.
    >> Share

  184. DUDREUILH C, Dorling A
    Effect of rituximab on anti-donor T-cell responses.
    Transpl Int. 2020;33:1322-1323.
    >> Share

  185. THOMPSON ER, Wilson CH
    Time to reflect, time to move on.
    Transpl Int. 2020;33:1185-1186.
    >> Share

    September 2020
  186. WIJTVLIET VPWM, Plaeke P, Abrams S, Hens N, et al
    Donor-derived cell-free dna as a biomarker for rejection after kidney transplantation: A systematic review and meta-analysis.
    Transpl Int. 2020 Sep 27. doi: 10.1111/tri.13753.
    >> Share

  187. PRYTULA A
    Tacrolimus exposure and intra-patient variability in paediatric and young adult kidney transplant recipients: one size does not fit all.
    Transpl Int. 2020 Sep 22. doi: 10.1111/tri.13750.
    >> Share

  188. NICHOLSON ML, Hoff M, Leighton P, Mohamed I, et al
    Pre-emptive immunosuppression using tacrolimus monotherapy does not reduce the rate of early acute rejection in renal transplantation from live donors: a comparative cohort study.
    Transpl Int. 2020 Sep 22. doi: 10.1111/tri.13747.
    >> Share

  189. PIERROTTI LC, Reusing Junior JO, Freire MP, Barros Machado DJ, et al
    COVID-19 among kidney transplant recipients requiring hospitalization: preliminary data and outcomes from a single-center in Brazil.
    Transpl Int. 2020 Sep 15. doi: 10.1111/tri.13745.
    >> Share

  190. BENONI H, Eloranta S, Dahle DO, Svensson MHS, et al
    Relative and absolute cancer risks among Nordic kidney transplant recipients - a population-based study.
    Transpl Int. 2020 Sep 8. doi: 10.1111/tri.13734.
    >> Share

  191. GOLD A, Tonshoff B, Dohler B, Susal C, et al
    Association of graft survival with tacrolimus exposure and late intra-patient tacrolimus variability in pediatric and young adult renal transplant recipients - An international CTS registry analysis.
    Transpl Int. 2020 Sep 2. doi: 10.1111/tri.13726.
    >> Share

    August 2020
  192. SCANDLING JD
    The center effect in kidney transplantation.
    Transpl Int. 2020 Aug 13. doi: 10.1111/tri.13719.
    >> Share

  193. GUPTA G, Raynaud M, Kumar D, Sanghi P, et al
    Impact of Belatacept Conversion on Kidney Transplant Function, Histology and Gene Expression.
    Transpl Int. 2020 Aug 13. doi: 10.1111/tri.13718.
    >> Share

  194. YUSUKE O, Streja E, Rhee CM, Tantisattamo E, et al
    Association of Age with Risk of First and Subsequent Allograft Failure and Mortality among Young Kidney Transplant Recipients in the USA.
    Transpl Int. 2020 Aug 11. doi: 10.1111/tri.13717.
    >> Share

  195. ARNOL M, Smrkolj T, Avsec D, Gadzijev A, et al
    An increase in kidney transplantation procedures from deceased donors during the COVID-19 epidemic in Slovenia.
    Transpl Int. 2020 Aug 7. doi: 10.1111/tri.13715.
    >> Share

  196. MEZIYERH S, van der Helm D, de Vries APJ
    Vulnerabilities in kidney transplant recipients with COVID-19: a single center experience.
    Transpl Int. 2020 Aug 7. doi: 10.1111/tri.13714.
    >> Share

    July 2020
  197. VAROTTI G, Dodi F, Garibotto G, Fontana I, et al
    Successful Kidney Transplantation after COVID-19.
    Transpl Int. 2020 Jul 24. doi: 10.1111/tri.13703.
    >> Share

  198. KINOSHITA Y, Yagisawa T, Sugihara T, Hara K, et al
    Clinical outcomes in donors and recipients of kidney transplantations involving medically complex living donors.
    Transpl Int. 2020 Jul 12. doi: 10.1111/tri.13699.
    >> Share

  199. SIVARAJ S, Chan A, Pasini E, Chen E, et al
    Enteric Dysbiosis in Liver and Kidney Transplant Recipients: A Systematic Review.
    Transpl Int. 2020 Jul 8. doi: 10.1111/tri.13696.
    >> Share

  200. GUHA C, Tong A, Baumgart A, Scholes-Robertson N, et al
    Suspension and resumption of kidney transplant programs during the COVID-19 pandemic: perspectives from patients, caregivers and potential living donors-a qualitative study.
    Transpl Int. 2020 Jul 8. doi: 10.1111/tri.13697.
    >> Share

  201. PARAJULI S, Mandelbrot DA
    One more time, emphasizing the advantage of simultaneous pancreas and kidney transplantation for patients with type 1 diabetes and end-stage renal disease.
    Transpl Int. 2020 Jul 3. doi: 10.1111/tri.13686.
    >> Share

  202. HOLT SG, Kotagiri P, Hogan C, Hughes P, et al
    The potential role of antibodies against minor blood group antigens in renal transplantation.
    Transpl Int. 2020 Jul 3. doi: 10.1111/tri.13685.
    >> Share

  203. VELIOGLU A, Tuglular S
    Care of Asymptomatic SARS-CoV-2 positive Kidney Transplant Recipients.
    Transpl Int. 2020 Jul 2. doi: 10.1111/tri.13691.
    >> Share

  204. SHARIF A, Lavee J, Baquero A, Fiatarone Singh M, et al
    Reply to Chen et al.
    Transpl Int. 2020;33:819-820.
    >> Share

    June 2020
  205. HTAY H, Pascoe EM, Hawley CM, Campbell SB, et al
    Patient and center characteristics associated with kidney transplant outcomes: a binational registry analysis.
    Transpl Int. 2020 Jun 26. doi: 10.1111/tri.13681.
    >> Share

  206. HE B, Ng ZQ, Mou L, Delriviere L, et al
    Long Term Outcome of Kidney Transplant by Using Restored Kidney Grafts after Tumour ex vivo Excision - A prospective study.
    Transpl Int. 2020 Jun 26. doi: 10.1111/tri.13682.
    >> Share

  207. SHINGDE R, Calisa V, Craig JC, Chapman JR, et al
    Relative survival and quality of life benefits of pancreas-kidney transplantation, deceased kidney transplantation, and dialysis in type 1 diabetes mellitus - a probabilistic simulation model.
    Transpl Int. 2020 Jun 23. doi: 10.1111/tri.13679.
    >> Share

  208. GIBBONS A, Cinnirella M, Bayfield J, Watson CJE, et al
    Changes in quality of life, health status, and other patient-reported outcomes following Simultaneous Pancreas and Kidney Transplantation (SPKT): a quantitative and qualitative analysis within a UK-wide programme.
    Transpl Int. 2020 Jun 20. doi: 10.1111/tri.13677.
    >> Share

  209. SCANDLING JD
    The weekend effect and workforce in kidney transplantation.
    Transpl Int. 2020 Jun 19. doi: 10.1111/tri.13676.
    >> Share

  210. SURESHKUMAR KK, Lyons S, Chopra B
    Impact of Kidney Transplant Type and Previous Transplant on Baseline Donor-Derived Cell Free DNA.
    Transpl Int. 2020 Jun 11. doi: 10.1111/tri.13673.
    >> Share

  211. VIKLICKY O, Krivanec S, Vavrinova H, Berlakovich G, et al
    Crossing borders to facilitate live donor kidney transplantation: the Czech-Austrian kidney paired donation program.
    Transpl Int. 2020 Jun 3. doi: 10.1111/tri.13668.
    >> Share

  212. SINGH R, Peters-Sengers H, Remmerswaal EBM, Yapici U, et al
    Clinical consequences of primary CMV infection after renal transplantation: a case-control study.
    Transpl Int. 2020 Jun 1. doi: 10.1111/tri.13667.
    >> Share

  213. PARAJULI S, Swanson K, Patel R, Astor BC, et al
    Outcomes of simultaneous pancreas and kidney transplants based on preemptive transplant compared to those who were on dialysis before transplant.
    Transpl Int. 2020 Jun 1. doi: 10.1111/tri.13665.
    >> Share

  214. BABU A, Khovanova N, Shaw O, Griffin S, et al
    C3d positive donor-specific antibodies have a role in pre-transplant risk stratification of crossmatch positive HLA-incompatible renal transplantation: United Kingdom multicentre study.
    Transpl Int. 2020 Jun 1. doi: 10.1111/tri.13663.
    >> Share

  215. SHARIF A
    Improved decision making in living donor kidney transplantation using health data research.
    Transpl Int. 2020 Jun 1. doi: 10.1111/tri.13666.
    >> Share

  216. PRAVISANI R, Guzzi G, Baccarani U, Avital I, et al
    Machine perfusion use for combined staged kidney transplantation after heart re-transplantation: keep calm and stabilize the recipient!
    Transpl Int. 2020 Jun 1. doi: 10.1111/tri.13660.
    >> Share

    May 2020
  217. VILLE S, Branchereau J, Cornuaud A, Dantal J, et al
    The weekend effect in kidney transplantation outcomes: a French cohort-based study.
    Transpl Int. 2020 May 19. doi: 10.1111/tri.13653.
    >> Share

  218. VILLE S, Dantal J
    Multi-target anti-EBV therapy for prevent primary infection in kidney transplant recipients from deceased donor, at risk of post transplantation lymphoproliferative disorder (EBV D+/R-).
    Transpl Int. 2020 May 17. doi: 10.1111/tri.13652.
    >> Share

  219. ARIAS-CABRALES CE, Perez-Saez MJ, Redondo-Pachon D, Buxeda A, et al
    Relevance of KDPI value and acute rejection on kidney transplant outcomes in recipients with delayed graft function- A retrospective study.
    Transpl Int. 2020 May 17. doi: 10.1111/tri.13654.
    >> Share

  220. OOMS LSS, Minnee RC, Dor FJMF, Kimenai HJAN, et al
    Stenting the ureteroneocystostomy reduces urological complications in kidney transplantation: a non-inferiority randomized controlled trial, SPLINT-trial.
    Transpl Int. 2020 May 13. doi: 10.1111/tri.13638.
    >> Share

  221. GAILLARD M, Tranchart H, Beaudreuil S, Lebrun A, et al
    Laparoscopic sleeve gastrectomy for morbid obesity in renal transplantation candidates: a matched case-control study.
    Transpl Int. 2020 May 12. doi: 10.1111/tri.13637.
    >> Share

  222. BELLINI MI, Tortorici F, Capogni M
    Kidney transplantation and the lock-down effect.
    Transpl Int. 2020 May 9. doi: 10.1111/tri.13639.
    >> Share

  223. LI Y, Yang N, Li X, Wang J, et al
    Strategies for Prevention and Control of the 2019 Novel Coronavirus Disease in the Department of Kidney Transplantation.
    Transpl Int. 2020 May 1. doi: 10.1111/tri.13634.
    >> Share

  224. BILLAH M, Santeusanio A, Delaney V, Cravedi P, et al
    A Catabolic State in a Kidney Transplant Recipient with COVID-19.
    Transpl Int. 2020 May 1. doi: 10.1111/tri.13635.
    >> Share

    April 2020
  225. SHI B
    Kidney Transplant Quality Control Center of National Health Commission, The 8th Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
    Transpl Int. 2020 Apr 27. doi: 10.1111/tri.13631.
    >> Share

  226. GATAULT P, Lajoie L, Stojanova J, Halimi JM, et al
    The FcgammaRIIIA-158 VV genotype increased the risk of post-transplant lymphoproliferative disorder in T-cell depleted kidney transplant recipients.
    Transpl Int. 2020 Apr 21. doi: 10.1111/tri.13624.
    >> Share

  227. NOBLE J, Maniere L, Pernollet M, Jacob MC, et al
    Baseline anti-CMV cellular immunity is similar between patients with a kidney transplant or receiving hemodialysis.
    Transpl Int. 2020 Apr 20. doi: 10.1111/tri.13620.
    >> Share

  228. BAILLY E, Ville S, Blancho G, Morelon E, et al
    An extension of the RITUX-ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody-mediated rejection after renal transplantation.
    Transpl Int. 2020 Apr 12. doi: 10.1111/tri.13613.
    >> Share

    January 2020
  229. SHARIF A
    Should donor body mass index influence kidney utilization by transplant centers?
    Transpl Int. 2020;33:56-58.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016